The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with α-catenin: Implications for inflammatory bowel diseases

Hormone and Metabolic Research

Volumn 39, Issue 8, 2007, Pages 601-611

  Orso E ^a,b   Moehle, C ^b   Boettcher, A ^b   Szakszon, K ^b   Werner, T ^b   Langmann, T ^b   Liebisch, G ^b   Buechler, C ^b   Ritter, M ^b   Kronenberg, F ^c   Dieplinger, H ^c   Bornstein, S R ^d   Stremmel, W ^e   Schmitz, G ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Apolipoproteins; Catenins; Inflammatory bowel disease; Intestinal permeability; Junctional integrity

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA CATENIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; CYCLINE; DNA;

ARTICLE; CELL FRACTIONATION; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; COLON BIOPSY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENTERITIS; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PSYCHOPHYSIOLOGY; SCREENING TEST; UPREGULATION; YEAST;

ALPHA CATENIN; APOLIPOPROTEINS A; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; GENE EXPRESSION PROFILING; GREEN FLUORESCENT PROTEINS; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERCELLULAR JUNCTIONS; INTESTINAL MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SATIATION; TRANSFECTION;

EID: 34548332524     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-984466     Document Type: Article

References (55)

1. Weinberg RB. Apolipoprotein A-IV polymorphisms and diet-gene interactions. Curr Opin Lipidol 2002; 13: 125-134
2. Green PH, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911-919
3. Wu AL, Windmueller HG. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem 1979; 254: 7316-7322
4. Liu M, Doi T, Shen L, Woods SC, Seeley RJ, Zheng S, Jackman A, Tso P. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1382-R1387
5. Tso P, Sun W, Liu M. Gastrointestinal satiety signals IV. Apolipoprotein A-IV. Am J Physiol Gastrointest Liver Physiol 2004; 286: G885-G890
6. Lu S, Yao Y, Cheng X, Mitchell S, Leng S, Meng S, Gallagher JW, Shelness GS, Morris GS, Mahan J, Erase S, Mansbach CM, Weinberg RB, Black DD. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size. J Biol Chem 2006; 281: 3473-3483
7. Qin X, Swertfeger DK, Zheng S, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol 1998; 274: H1836-H1840
8. Ferretti G, Bacchetti T, Bicchiega V, Curatola G. Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins. Chem Phys Lipids 2002; 114: 45-54
9. Thorngate FE, Yancey PG, Kellner-Weibel G, Rudel LL, Rothblat GH, Williams DL. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression. J Lipid Res 2003; 44: 2331-2338
10. Emmanuel F, Steinmetz A, Rosseneu M, Brasseur R, Gosselet N, Attenot F, Cuine S, Seguret S, Latta M, Fruchart JC, Denéfle P. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation. J Biol Chem 1994; 269: 29883-29890
11. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, Denéfle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 1996; 273: 966-968
12. Cohen RD, Castellani LW, Qiao JH, Lenten BJ Van, Lusis AJ, Reue K. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 1997; 99: 1906-1916
13. Kronenberg F, Stuhlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, Eckardstein A von, Dieplinger H. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 2000; 36: 751-757
14. Wong WM, Hawe E, Li LK, Miller GJ, Nicaud V, Pennacchio LA, Humphries SE, Talmud PJ. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res 2003; 92: 969-975
15. Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro C, Zakin MM, Scott-Algara D. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler Thromb Vasc Biol 2004; 24: 756-761
16. Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Tumage RH, Davidson WS, Tso P, Granger DN, Kalogeris TJ. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest 2004; 114: 260-269
17. Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A, Stremmel W, Schmitz G. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004; 127: 26-40
18. Edens HA, Levi BP, Jaye DL, Walsh S, Reaves TA, Turner JR, Nusrat A, Parkos CA. Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration. J Immunol 2002; 169: 476-486
19. Dieplinger H, Lobentanz EM, Konig P, Graf H, Sandholzer C, Matthys E, Rosseneu M, Utermann G. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest 1992; 22: 166-174
20. Langmann T, Mauerer R, Zahn A, Moehle C, Probst M, Stremmel W, Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem 2003; 49: 230-238
21. Ritter M, Buechler C, Boettcher A, Barlage S, Schmitz-Madry A, Orsó E, Bared SM, Schmiedeknecht G, Baehr CH, Fricker G, Schmitz G. Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics 2002; 79: 693-702
22. Sambrook JRDW. Molecular Cloning, a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001
23. Bottcher A, Mollers C, Lackner KJ, Schmitz G. Automated free-solution isotachophoresis: instrumentation and fractionation of human serum proteins. Electrophoresis 1998; 19: 1110-1116
24. Bottcher A, Schlosser J, Kronenberg F, Dieplinger H, Knipping G, Lackner KJ, Schmitz G. Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions. J Lipid Res 2000; 41: 905-915
25. Drobnik W, Borsukova H, Boettcher A, Pfeiffer A, Liebisch G, Schuetz GJ, Schindler H, Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 2002; 3: 268-278
26. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736-749
27. Lindhardt K, Bechgaard E. Sodium glycocholate transport across Caco-2 cell monolayers, and the enhancement of mannitol transport relative to transepithelial electrical resistance. Int J Pharm 2003; 252: 181-186
28. Beavon IR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000; 36: 1607-1620
29. Havel RJ, Cane JP. Introduction: structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Vail D, Childs B, Kinzler KW, Vogelstein B (eds). The metabolic and molecular bases of inherited disease 8th Ed. New York: McGraw-Hill Medical Publishing, 2001; 2705-271
30. Zhang S, Janciauskiene S. Multi-functional capability of proteins: alphal-antichymotrypsin and the correlation with Alzheimer's disease. J Alzheimers Dis 2002; 4: 115-122
31. Ren S, Rollins BJ. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 2004; 117: 239-251
32. Rickert P, Seghezzi W, Shanahan F, Cho H, Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 1996; 12: 2631-2640
33. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL. Tight junctions are membrane microdomains. J Cell Sci 2000; 113: 1771-1781
34. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004; 84: 282-291
35. Leblond CP. The life history of cells in renewing systems. Am J Anat 1981; 160: 114-158
36. Podolsky DK, Babyatsky WW. Growth and development of the gastrointestinal tract. In: Yamada T (ed). Textbook of Gastroenterology. Philadelphia: J. B. Lippincott, 1999; 547-584
37. Laprise P, Chailler P, Houde M, Beaulieu JF, Boucher MJ, Rivard N. Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation. J Biol Chem 2002; 277: 8226-8234
38. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO, Schulzke JD. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999; 116: 301-309
39. Groenendijk M, Bruin TW De, Dallinga-Thie GM. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia. Atherosclerosis 2001; 158: 369-376
40. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002; 11: 3039-3046
41. Pennacchio LA, Rubin EM. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 2003; 23: 529-534
42. Vliet HN Van der, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 2001; 276: 44512-44520
43. Reisher SR, Hughes TE, Ordovas JM, Schaefer EJ, Feinstein SI. Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2. Proc Natl Acad Sci USA 1993; 90: 5757-5761
44. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 1997; 13: 119-146
45. Balda MS, Matter K. Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 2003; 13: 310-318
46. Giannini A, Mazor M, Orme M, Vivanco M, Waxman J, Kypta R. Nuclear export of alpha-catenin: overlap between nuclear export signal sequences and the beta-catenin binding site. Exp Cell Res 2004; 295: 150-160
47. Aken E Van, Wever O De, Correia da Rocha AS, Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 2001; 439: 725-751
48. Basque JR, Levy E, Beaulieu JF, Menard D. Apolipoproteins in human fetal colon: immunolocalization, biogenesis, and hormonal regulation. J Cell Biochem 1998; 70: 354-365
49. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermueller N, Otto HF, Autschbach F. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281: G216-G228
50. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001; 159: 2001-2009
51. Bergman D, Kadner SS, Cruz MR, Esterman AL, Tahery MM, Young BK, Finlay TH. Synthesis of alpha 1-antichymotrypsin and alpha 1-antitrypsin by human trophoblast. Pediatr Res 1993; 34: 312-317
52. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268: 14116-14124
53. Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 1999; 163: 2792-2798
54. Abraham CR. Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease. Neurobiol Aging 2001; 22: 931-936
55. Bergstrom J, Murphy CL, Weiss DT, Solomon A, Sletten K, Hellman U, Westermark P. Two different types of amyloid deposits - apolipoprotein A-IV and transthyretin - in a patient with systemic amyloidosis. Lab Invest 2004; 84: 981-988